Rundu Shares: Subsidiary's Tobacco Monopoly Production Enterprise License validity extended
Rundu Shares announced on July 15 the extension of the production enterprise license for its wholly-owned subsidiary, Rundu Pharmaceutical (Jingmen) Co., Ltd. The announcement mentioned that the subsidiary recently received the "Tobacco Monopoly Production Enterprise License" issued by the National Tobacco Monopoly Administration for the production of nicotine for e-cigarettes. This license has been updated to reflect changes in production scale and has been extended until June 30, 2025.
The acquisition of the "Tobacco Monopoly Production Enterprise License" by Rundu Jingmen Company signifies its legal ability to produce and sell (domestically and for export) nicotine for e-cigarettes, which will have a positive impact on the company's performance.
The announcement is as follows:




